NASDAQ:IOVA

Iovance Biotherapeutics Stock Predictions

etoro logo Buy IOVA
*Your capital is at risk
$3.79
-0.310 (-7.56%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

IOVA Prediction Chart

IOVA Predictions History

Latest community submissions for IOVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 2, 2024 $8.43 +3.64% $8.10 X 95.98% 0
Jan 2, 2024 $5.00 -38.50% $8.10 V 61.73% 1
May 31, 2023 $8.59 -2.98% $8.74 V 98.24% 1
May 31, 2023 $8.69 -1.86% $8.74 V 99.37% 4
May 31, 2023 Bullish $8.74 V 0
Feb 6, 2023 $7.80 -2.22% $8.20 X 95.16% 0
Feb 6, 2023 $7.87 -1.39% $8.20 X 95.97% 0
Feb 6, 2023 Bearish $8.20 X 0
JS JS Pro
Jan 6, 2021 $44.10 -5.87% $46.85 X 94.13% 0
Andy Jackson Andy Jackson @AndyJackson.184174
Jan 6, 2021 Bearish $46.85 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for IOVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT IOVANCE BIOTHERAPEUTICS, INC.
Iovance Biotherapeutics
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or pers...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE